CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- operating
- EIN
- 821436829
- Phone
- (256) 327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- 4 Planned sale Chief Scientific Officer sold 6,500 shares at $5.67 ($36,855)
- 4 Planned sale Chief Scientific Officer sold 6,500 shares at $5.78 ($37,570)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Chief Executive Officer acquired 95,730 shares (other)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award 10% owner acquired 1,000,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 3,866 shares at $4.59 ($17,745)
- 4 Open-market buy Director bought 1,137 shares at $6.03 ($6,851)
- 4 Open-market buy Director bought 14,388 shares at an average $6.13 ($88,257)
- 4 Open-market buy Director bought 6,000 shares at $6.47 ($38,814)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,776 shares at $8.25 ($14,652)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 4 of 9 · 177 filings